Research & development

With 25 % of turnover (excluding generics) invested each year in Research and Development, Servier contributes actively to the development of pharmaceutical innovation and to medical progress in five areas: cardiovascular diseases, diabetes, cancer, immune-inflammatory diseases and neuro-degenerative diseases.

Icon R & D

With 19 therapeutic research centers and 3 discovery research centers, nearly 2200 R&D employees worldwide join forces to improve patients’ health.

3,000 employees in R & D - 250 partnerships

Our Group banks on complementary know-how and sharing of expertise to meet patients’ needs with more than 250 partnerships established worldwide.

This approach, based on open innovation, energizes our research activities and facilitates the discovery of innovative therapeutic solutions.

The R&D department offers a wide choice of professions participating in all stages of the discovery of a new drug:

  • Biotechnology,
  • Medicinal and analytical chemistry,
  • Pharmacology,
  • Pharmacokinetics,
  • Galenics,
  • Toxicology, etc.
  • Quality assurance,
  • Biostatistics,
  • Data management,
  • Technical regulatory affairs,
  • Project management,
  • Study logistics,
  • Development of protocols, etc.


Factory Photo

In our 15 clinical and pharmaceutical production sites worldwide, nearly 4300 employees are involved in the manufacturing, packaging and distribution of our drugs with worldwide production of 617 million boxes per year.

Production icon

In accordance with the standards in force, our production processes aim to supply the best pharmaceutical quality for patients.

Continuous modernization of our industrial equipment gives the teams the means to work in an optimal and secure environment.

Sustainable development is at the heart of our corporate social policy. We are actively committed to preservation of the environment through the design of "green and sustainable" factories focused on saving resources and developing renewable energy sources.

A host of professions are involved in the drug production chain:

  • Industrial transposition,
  • Quality assurance,
  • Production management,
  • Logistics / Supply Chain,
  • Pharmaceutical responsibility.

Commercial operations

Providing health professionals with the highest quality of information is one of the Group’s priorities. Our aim is to provide doctors with full knowledge of our drugs in order to constantly improve patients’ quality of life.

Sales illustration

Numerous employees contribute to the improvement of our medical communication, the development of our reputation in scientific innovation and the maintaining of sustainable growth for our investments in pharmaceutical research.

Sales icon

Our promotional activities offer numerous prospects in several disciplines:

  • Promotion,
  • Medical visits,
  • Network training,
  • Market studies,
  • Scientific reputation,
  • Regulatory affairs.

Cross-functional positions

Photo of cross-functions

Cross-departmental functions are essential to the smooth running of our organization and group together resources management and steering activities and means common to the company’s various business lines.

Optimum allocation of our resources is essential for adapting as effectively as possible to an ever-changing environment. Cooperation between departments is a driving force for performance which guarantees the efficiency of our processes and the dynamism of our teams.

Cross-functions icon

Cross-departmental functions offer numerous opportunities in various fields of activity:

  • Human resources,
  • Communication,
  • Legal,
  • Financial,
  • Information systems,
  • Purchasing,
  • Regulatory affairs.